Dear Colleague,
On July 19 to 24th , 2009 we will host the 5th International
Veterinary Vaccines and Diagnostics Conference (IVVDC) in Madison, WI
USA. The First IVVDC Conference was held in Madison WI in 1997
(Chair R.D. Schultz), the 2nd in Oxford England 2000 (Chair Lewis Thomas), the
3rd in Guelph Canada 2003 (Chair Pat Shewen) and the 4th in Oslo Norway 2006
(Chair Arve Lund). These were all excellent conferences! The
original and continuing purpose of the IVVDC is to bring together people from
the Private Sector (Industry, Veterinary Practice and the Public Sector
(Government and Academia) to discuss issues pertaining to the development and
use of all Veterinary Vaccines and Diagnostics for multiple animal
species. We decided to hold the 5th IVVDC again in Madison WI to honor
many of the individuals, including those that have retired, who have made and
continue to make major contributions to Veterinary Immunology and Microbiology
and especially to those that have made major contributions in Veterinary
Vaccinology and Diagnostics.
This Conference Series without exception provides more information on
vaccines and diagnostics for all veterinary species than any other meeting you
can attend.
This years conference, similar to previous years, will have concurrent
Sessions on Vaccines and Diagnostics for multiple species including: Avian and
Aquatic, Bovine, Canine and Feline, Equine, Human, Porcine, Wild and Exotic.
Presentations include information on vaccines that not only control or prevent
infectious diseases caused by Viruses, Bacteria
and/or Parasites, but also vaccines designed for treating, controlling
and/or preventing Cancers, Periodontal Disease, Pregnancy,
Snakebites, etc.
Sessions will also include: Regulations and Licensing; Immunologic Reagents;
Food Safety; Basic Immunology (Adaptive and Innate Immunity); Bioterrorism;
Foreign Animal Diseases; Adverse Reactions and/or Undesirable Consequences from
Vaccines and/or Diagnostics; Marker (DIVA) Vaccines; Herd (Population)
Immunity; Specific Disease Eradication Programs; Development of both New
Traditional, and Recombinant DNA, Infectious
and Non-Infectious Vaccines; Natural Immunization; Traditional and Molecular
Methods for Discovery and Diagnosis.
You will not want to miss this conference because the information
will be presented by experts from around the world with many years of
experience on the topics they present. Also the audience will include
many with years of experience in vaccinology, which will provide an opportunity
for many very interesting discussions.
The 5th IVVDC is Sponsored by the Following Organizations:
International Veterinary Vaccines and Diagnostics Committee, American Association
of Veterinary Immunologists, Veterinary Immunology Committee, AAHAs Canine
Vaccine Task Force, American Association of Feline Practitioners (AAFP) Vaccine
Task Force and World Small Animal Veterinary Vaccine Group (WSAVVG)
Dr. Ronald David Schultz
Professor and Chair
Department of Pathobiological Sciences
School of Veterinary Medicine
University of Wisconsin-Madison
Corporate Sponsors include but are not limited to:
Additional Corporate Sponsors will be listed in detail at a later time.
Program
Sunday, July 19
12:00 Noon 5:30 PM
Introduction and General Topics
|
12:00 - 1:00
|
Welcoming Ceremony
|
|
1:00 - 1:45
|
Tizard, Ian
Dr. Ian Tizard, Professor, Texas A&M University, College Station, TX
Variolation and vaccination in domestic animals the earliest
attempts to protect against infectious diseases
|
|
1:45 - 2:30
|
Bergman, Philip
Dr. Philip Bergman, BrightHeart Veterinary Centers, Armonk, NY
Of Mice & Men (& Dogs!): Therapeutic Vaccines for Cancer??
|
|
2:30 - 3:15
|
Kawaoka, Yoshi
Dr. Yoshi Kawaoka, Department of Pathobiological Sciences, Influenza Research
Institute, University of Wisconsin-Madison
Why influenza kills and how to prevent it from killing again
|
|
3:15 - 3:30
|
Break
|
|
3:30 4:15
|
Cook, Mark
Dr. Mark Cook, Department of Animal Sciences, University of Wisconsin-Madison
Vaccination Taxation
|
|
4:15 5:00
|
Suresh, M.
Dr. M. Suresh, Department of Pathobilogical Sciences, University of
Wisconsin-Madison
Cell Cycle Regulator p27Kip1 Constrains the Quantity and Quality of
CD8 T Cell Memory by Regulating the Number of Memory Precursor Effector Cells
|
|
5:00 5:30
|
Walker, John
Dr. John Walker, Pfizer Animal Health, Parkville Australia
Peptide conjugate vaccines for immuno-contraception -
commercialization by species
|
|
5:30 - 6:00
|
Q&A
|
|
6:30 9:30
|
Opening Reception
|
Monday, July 20
Bovine AM Session A : 8:15 12:00
Co-Chairs: Dr. Pat Shewen and Dr. Jim Roth
|
8:15 8:30
|
Intro by Co-Chairs
|
|
8:30-9:00
|
Collins, Mike
Dr. Mike Collins, University of Wisconsin-Madison
Johnes disease diagnostics: The right test at the right time for the
right price
|
|
9:00 9:30
|
Talaat, Adel
Dr. Adel Talaat, School of Veterinary Medicine, University of Wisconsin-
Madison
On the Road to Discovery of Novel Vaccines Against Johnes Disease in
Cattle
|
|
9:30 10:00
|
Baldwin, Cynthia
Dr. Cynthia Baldwin, Univ. of Mass, Dept. of Veterinary and Animal Science,
Amherst MA
Involvement of bovine gamma delta T cells in the immune response
stimulated by a protective vaccine against Leptospira serovar Hardjo
|
|
10:00 10:30
|
Break
|
|
10:30 11:00
|
Kehrli, Marcus
Dr. Marcus Kehrli, Agricultural Research Service, USDA, NADC,
Ames, IA
Innovative disease prevention research and a few reasons for
commercial failure.
|
|
11:00 11:30
|
Potter, Andrew
Dr. Andrew Potter, Director and CEO, VIDO, Saskatoon, SK CANADA
Vaccination as a tool to reduce shedding of shigatoxin-producing Escherichia
coli by cattle
|
|
11:30 12:00
|
Q&A or Poster Oral Presentations
|
|
12:00 1:30
|
Lunch
|
|
Bovine PM Session: 1:30 5:30
Co-Chairs: Dr. Gerhardt Schurig and Dr. Marcus Kehrli
|
|
1:30 1:45
|
Intro by Co-Chairs
|
|
1:45 2:15
|
Corbeil, Lynette
Dr. Lynette Corbeil, University of California-San Diego
Histophilus somni IbpA: diagnostic, protective and toxic domains
|
|
2:15 2:45
|
Shewen, Patricia
Dr. Patricia Shewen, Department of Pathobiology, Ontario Veterinary College,
University of Guelph, Guelph, Ontario CANADA
Vaccination of Neonatal Calves: Obstacles and Opportunities
|
|
2:45 3:15
|
Czuprynski, Chuck
Dr. Chuck Czuprynski, Department of Pathobiological Sciences, University of
Wisconsin-Madison
Bovine cell interactions with Mannheimia haemolytica and Histophilus
somni
|
|
3:15 3:30
|
Break
|
|
3:30 4:00
|
Roth, James
Dr. James A. Roth, Director, Center for Food Security and Public Health
Executive Director, Institute for International Cooperation in Animal
Biologics, College of Veterinary Medicine, Iowa State University, Ames, Iowa
50011
Induction of T Cell-Mediated Immunity by Bovine Vaccines
|
|
4:00 4:30
|
Dubovi, Ed
Dr. Edward Dubovi, NY State Diagnostic Laboratory, Cornell University
Diagnostic Testing as a Key Component of a BVDV Control Program
|
|
4:30 5:30
|
Q&A or Poster Oral Presentations
|
|
Canine and Feline AM Session: 8:15 12:00
Co-Chairs: Dr. Max Appel and Dr. Fred Scott
|
|
8:15 8:30
|
Intro by Co-chairs
|
|
8:30 9:00
|
Lappin, Mike
Dr. Mike Lappin, Department of Clinical Sciences, Colorado State University,
Ft. Collins, CO
Antibodies against feline tissues induced by vaccination
|
|
9:00 9:30
|
Lutz, Hans
Dr. Hans Lutz, Head, Clinical Laboratory, Vetsuisse Faculty, University of
Zurich, Zurich, Switzerland
Diagnosis of Feline Leukemia Virus infection the basis for
eradication
|
|
9:30 10:00
|
LaFleur, Rhonda
Dr. Rhonda LaFleur, Intervet/Schering-Plough Animal Hlth, Elkhorn NE
A Novel Borrelia burgdorferi Bacterin that induces both OSPA and OSPC
Borreliacidal Antibodies Protects Dogs against Lyme Disease
|
|
10:00 10:30
|
Break
|
|
10:30 11:00
|
Pardo, Camila
Dr. M. Camila Pardo, Merial, Athens GA
Prevention of Canine leptospirosis and leptospiruria caused by L.
grippotyphosa, 15 months after last vaccination
|
|
11:00 11:30
|
Martella, Vito
Dr. Vito Martella, School of Veterinary Medicine, Bari, Italy
Discovery of new canine enteric viruses
|
|
11:30 12:00
|
Q&A or Poster Oral Presentations
|
|
12:00 1:30
|
Lunch
|
|
Canine & Feline PM Session: 1:30 - 5:30
Co-Chairs: Dr. Gilles Chappius, Dr. Skip Carmichael
|
|
1:15 1:45
|
Carmichael, Leland (Skip)
Dr. Leland (Skip) Carmichael, Baker Institute, Cornell University
Canine parvovirus type-2: Then and 31 years later.
|
|
1:45 2:15
|
Wasmoen, Terri
Dr. Terri Wasmoen, Sr. Director, Biological Research, Intervet/Schering
Plough Inc., 21401 West Center Road, Elkhorn NE 68022
Canine Influenza Virus: Experimental disease and prevention with
vaccination
|
|
2:15 2:45
|
Kapil, Sanjay
Dr. Sanjay Kapil, Oklahoma State Univ., Diagnostic Lab, Stillwater OK
Canine Parvovirus: An Emerging, Reemerging Significant Pathogen of
Dogs
|
|
2:45 3:15
|
Dodds, W.J.
Dr. Jean Dodds, Hemopet, Santa Monica, CA.
Compliance or resistance to current vaccine guidelines?
|
|
3:15 3:30
|
Break
|
|
3:30 4:00
|
Ford, Rich
Dr. Rich Ford, North Carolina State University, College of Vet Medicine
"Post-vaccinal Ischemic Vasculitis in Dogs: Satellite Skin
Lesions"
|
|
4:00 4:30
|
Moore, George
Dr. George Moore, Purdue University, West Layfayette IN
Antigenic Causes of Vaccine-Associated Allergic Reactions in Dogs
|
|
4:30 5:00
|
Osorio, J.E.
Dr. Jorge Osorio, Department of Pathobiological Sciences, University of
Wisconsin-Madison
Development of oral raccoon pox based vaccines that protect black- tailed
prairie dogs against plague
|
|
5:00 5:30
|
Decaro, Nicola
Dr. Nicola Decaro, School of Veterinary Medicine, Bari, Italy
An Update on Canine Coronaviruses
|
|
5:30 6:00
|
Q&A
|
Tuesday, July 21
Canine/Feline AM Session: 8:15 12:00
Co-Chairs: Dr. Ilona Rodan, Dr. Mike Paul
|
8:15 - 8:30
|
Intro by Co-Chairs
|
|
8:30 9:00
|
Leutenegger, Christian
Dr. Christian Leutenegger, Idexx Laboratories, Sacramento, CA
Molecular Diagnostics and Vaccination: Dealing with Interference and
Rates of False Positive Results
|
|
9:00 9:30
|
Evermann, Jim
Dr. James Evermann, Washington State University, Diagnostic Lab
Evolution of a Diagnosis: The Technology is Changing, but the Basic
Principles Remain the Same
|
|
9:30 10:00
|
Pedersen, Niels
Dr. Niels Pedersen, UC-Davis, Davis CA
Feline infectious Peritonitis Dilemmas of diagnosis, treatment and
vaccination
|
|
10:00 10:30
|
Break
|
|
10:30 11:00
|
Leard, Tim
Dr. Timothy Leard, Merial, Athens, GA
Animal Health Vaccine, The Path to Licensure Canine Melanoma DNA
Vaccine
|
|
11:00 11:30
|
Schultz, Ronald
Dr. Ronald Schultz, Department of Pathobiological Sciences, University of
Wisconsin-Madison
Canine and Feline Vaccine Questions: Do We Have the Answers?
|
|
11:30 12:00
|
Q&A Roundtable
|
|
12:00 1:30
|
Lunch
|
|
Swine PM Session: 1:30 5:45
Co-Chairs: Dr. Joan Lunney and Dr. Chris Olsen
|
|
1:30 1:45
|
Intro by Chairs
|
|
1:45 2:30
|
Butler, J.E.
Dr. J.E. Butler, Dept. of Microbiology, University of Iowa
The effect of PRRSV, SIV and PCV-2 on the humoral immune system of
germfree isolator piglets
|
|
2:30 3:15
|
Murtaugh, Michael
Dr. Michael Murtaugh, Dept. of Veterinary and Biomedical Sciences, University
of Minnesota
Imunological Constraints on Vaccine Development for PRRS
|
|
3:15 3:30
|
Break
|
|
3:30 4:15
|
Saif, Linda
Dr. Linda Saif, Food Animal Health Research Program, OARDC, Dept. Veterinary
Preventive Med, The Ohio State University, Wooster, OH USA
Gut reactions to rotavirus vaccines in a gnotobiotic piglet disease
model: a priming lesion for neonatal mucosal immunity
|
|
4:15 4:45
|
Yoo, Han Sang
Dr. Han Sang Yoo, Professor, Seoul National University
A novel swine atrophic rhinitis vaccine candidate that induces
mucosal immune responses by delivery systems based on chitosan microspheres
|
|
4:45 5:15
|
Thacker, Eileen
Dr. Eileen Thacker, USDA-Agricultural Research Service, Beltsville MD
The Autogenous Option
|
|
5:15 5:45
|
Vincent, Amy
Dr. Amy Vincent, National Animal Disease Center, USDA, ARS, Ames IA
Aggravated pneumonia induced by mismatched inactivated influenza
virus vaccines."
|
|
Equine AM Session: 8:00 12:00
Co-Chairs: Dr. Dave Horohov, Dr. Paul Lunn
|
|
8:00 8:30
|
Intro by David Horohov, University of Kentucky
|
|
8:30 9:15
|
Hines, Steve
Dr. Steve Hines, Washington State University, Pulllman, WA
Rhodococcus equi - immunity and strategies for prevention
|
|
9:15 9:45
|
Adams, Amanda
Dr. Amanda Adams, Maxwell H. Gluck Equine Research Center, University of KY
Comparison of humoral and cell-mediated immune responses of young and
old horses following influenza recombinant canarypox virus vaccination and
challenge
|
|
9:45 10:15
|
Chiang, Yu-Wei
Dr. Yu-Wei Chiang, Fort Dodge Animal Health
Development and Registration of Fort Dodge Animal Healths West Nile
Virus Vaccines
|
|
10:15 10:30
|
Break
|
|
10:30 11:00
|
Vaala, Wendy
Dr. Wendy Vaala, Intervet/Schering Plough
PreveNile and WNV prevention
|
|
11:00 11:30
|
Lunn, Paul
Dr. Paul Lunn, Colorado State University
New diseases, new vaccines, old challenges: the equine balance sheet
|
|
11:30 12:00
|
Q&A and/or poster presentations
|
|
12:00 1:30
|
Lunch
|
|
Equine PM Session: 1:30 5:30
Co-Chairs: Dr. Dave Horohov and Dr. Paul Lunn
|
|
1:30 1:45
|
Intro by Co-Chairs
|
|
1:45 2:15
|
Minke, Jules
Dr. Jules Minke, Merial, Lyon France
Field experience on ProteqFluฎ during the Australian outbreak
|
|
2:15 2:45
|
Osterrieder, Klaus
Dr. Klaus Osterrieder, Institut fur Virologie, Freie Universitat Berlin
Equine Herpesvirus Type 1 Novel Vectored Vaccines
|
|
2:45 3:15
|
Landolt, Gabi
Dr. Gabi Landolt, Colorado State Univ., Ft. Collins, CO
Past the Point of No Return? Of Horses, Dogs, and Influenza
|
|
3:15 3:30
|
Break
|
|
3:30 4:00
|
Timoney, John
Dr. John Timoney, Professor, Dept. of Veterinary Science, Maxwell H. Gluck
Equine Research Ctr., University of KY, Lexington, KY
Genomes of Streptococcus equi and zooepidemicus: Rosetta stones for
strangles vaccine improvement?
|
|
4:00 4:30
|
Stenbohm, Bob
Dr. Bob Stenbohm, Boehringer Ingelheim, St. Joseph, Missouri
Evaluation of the humoral immune response and fecal shedding in
weaning foals following oral and intra-rectal administration of an avirulent
live vaccine of Lawsonia intracellularis
|
|
4:30 5:00
|
Gershwin, Laurel
Dr. Laurel Gershwin, Professor of Immunology, University of California- Davis
Equine Vaccine Hypersensitivity
|
|
5:00 5:30
|
Q&A
|
Wednesday, July 22
New technologies to design vaccines for the control and eradication of
transboundary diseases (FAD) Session AM: 8:30 12:00
Co-Chairs: Dr. Cyril Gay, Dr. Paul-Pierre Pastoret
|
8:30 8:45
|
Intro by Co-Chairs
|
|
8:45 9:30
|
Pastoret, Paul-Pierre
Dr. Paul-Pierre Pastoret, OIE, World Organisation for Animal Health, Paris,
France
Vaccines in relation to trade and new and emerging technologies
|
|
9:30 10:15
|
Rodriguez, Luis
Dr. Luis Rodriguez, USDA/ARS Plum Island Animal Disease Center
The importance of basic research for the rational design of vaccines
|
|
10:15 10:30
|
Break
|
|
10:30 11:00
|
MacLachlan, Jim
Dr. James MacLachlan, Department of Pathology, Microbiology and Immunology,
UC-Davis
Recombinant Canarypox Virus Vaccines to Prevent Emerging Orbivirus
Diseases of Livestock
|
|
11:00 11:30
|
Vincent, Amy
Dr. Amy Vincent, NADC, ARS, Ames IA
New technologies to control Swine Influenza Virus
|
|
11:30 12:00
|
Posters
|
|
12:00 1:30
|
Lunch
|
|
New technologies to design vaccines for the
control and eradication of transboundary diseases (FAD) Session PM: 1:00
4:30
Co-Chairs: Dr. Cyril Gay, Dr. Paul-Pierre Pastoret
|
|
1:00 1:15
|
Intro by Co-Chairs
|
|
1:15 1:45
|
Dr. Cyril Gay
United States Dept. of Agriculture, Agriculture Research Service, Animal
Production and Protection, Beltsville, Maryland
New technologies to control Foot-and-Mouth Disease
|
|
1:45 2:15
|
Drew, Trevor
Dr. Trevor Drew, Veterinary Laboratories Agency, Weybridge, England
New technologies to control Classical Swine Fever (CSF)
|
|
2:15 2:45
|
Dungu, Baty
Dr. Baty Dungu, GALVmed, Edinburgh, Scotland
Prospects for improved Rift Valley Fever (RVF) vaccines
|
|
2:45 3:00
|
Break
|
|
3:00 3:30
|
Greenlee, Justin
Dr. Justin Greenlee, Virus and Prion Diseases of Livestock Research Unit,
National Animal Disease Center, Ames IA
New Potentials in TSE diagnostics
|
|
3:30 4:00
|
Posters
|
|
4:00 4:30
|
Q&A
|
|
EVENING
|
Concert on the Square
|
|
Avian/Aquatic AM Session: 8:30 12:00
Co-Chairs: Dr. Phil Klesius and Dr. Stacey Schultz-Cherry
|
|
8:30 8:45
|
Intro by Co-Chairs
|
|
8:45 9:30
|
Afonso, Claudio
Dr. Claudo Afonso, USDA-ARS, Southeast Poultry Research Lab, Athens, GA
New strategies to control virulent Newcastle disease
|
|
9:30 10:00
|
Schultz-Cherry, Stacey
Dr. Stacey Schultz-Cherry, Dept. Medical Microbiology, University
of Wisconsin-Madison
Astroviruses: Lessons
learned from turkeys
|
|
10:00 10:30
|
Break
|
|
10:30 11:00
|
Saif, Mo
Dr. Mo Saif, Ohio State University, Department of Animal Sciences, Columbus,
OH
Influenza Vaccines for Turkeys
|
|
11:00 11:45
|
Klesius, Phillip
Dr. Phillip Klesius, United States Dept. of Agriculture, Agricultural
Research Service, Aquatic Animal Health Research Laboratory, Auburn AL and
Chestertown MD USA
Fish Vaccines: Current State and Future Advances
|
|
11:45 12:00
|
Poster Session
|
|
12:00 1:30
|
Lunch
|
|
Avian/Aquatic PM Session: 1:30 4:30
Co-Chairs: Dr. Phil Klesius and Dr. Kathy Kurth
|
|
1:30 1:45
|
Intro by Co-Chairs
|
|
1:45 2:15
|
Adams, Alexandra
Dr. Alexandra Adams, Institute of Aquaculture,
Stirling, Scotland
UK
Novel approaches to fish vaccine development
|
|
2:15 2:45
|
Shoemaker, Craig
Dr. Craig A. Shoemaker, USDA, Aquatic Animal Health Reseach Lab, Auburn
AL
Development and use of a modified live Flavobacterium columnare
vaccine in fish
|
|
2:45 3:15
|
Kurth, Kathy
Dr. Kathy Kurth, Wisconsin Veterinary Diagnostic Lab, Madison
WI
Emerging Aquatic Viruses in Wisconsin
|
|
3:15 3:30
|
Break
|
|
3:30 4:00
|
N. Mirhossenini
Dr. N. Mirhosseini, Texas A&M
University, College
Station, TX
Serologic and molecular diagnosis of avian borna virus infection.
|
|
4:00 - 4:30
|
Cook, Stephanie
Dr. Stephanie Cook, Intervet Schering-Plough, Elkhorn,
NE
A Marek's Disease Virus Recombinant Vaccine to Control ILT and
Marek's Disease Siumltaneously.
|
|
4:30 5:00
|
Q&A and/or poster presentations
|
|
EVENING
|
Concert on the Square
|
Thursday, July 23
General Session: 8:30 11:45
Co-Chairs: Dr. Chuck Czuprynski and Dr. Gary Splitter
|
8:30 8:45
|
Intro by Co-Chairs
|
|
8:45 9:30
|
Audonnet, Jean-Christophe
Dr. Jean-Christophe Audonnet, Merial, Lyon France
20 years of experience with ALVAC as a vector for veterinary
vaccines.
|
|
9:30 10:15
|
Rouse, Barry
Dr. Barry Rouse, University of Tennessee-Knoxville
Immunopathology versus immunity in viral infections
|
|
10:15 11:00
|
Bror Morein
Dr. Bror Morein, Swedish University of Agricultural Sciences, Department of
Veterinary Microbiology, Uppsala, Sweden
ISCOM Technology: Its Importance in Designing Veterinary Vaccines
|
|
11:00 11:45
|
Meeusen, Els
Dr. Els Meeusen, Animal Biotech Research Laboratory, Dept. of Physiology,
School of Biomedical Sciences, Monash Univ, Victoria, Australia
Adjuvants in the real world how do they work?
|
|
11:45 1:00
|
Lunch
|
|
General Session PM: 1:00 4:30
Co-Chairs: Dr. Gary Splitter and Dr. Els Meeusen
|
|
1:00 1:15
|
Intro by Co-Chairs
|
|
1:15 2:00
|
Lunney, Joan
Dr. Joan Lunney, Animal Parasitic Diseases Lab, ANRI, ARS, USDA
Genetic approaches to reveal immune response pathways and viral
antigen targets for novel vaccine design
|
|
2:00 2:45
|
Splitter, Gary
Dr. Gary Splitter, Department of Pathobiological Sciences, University of
Wisconsin-Madison
Unraveling the secrets of Brucell abortus
|
|
2:45 - 3:30
|
Wiegers, Ann
Dr. Ann Wiegers, CVB, APHIS, USDA, Ames,
IA
General Licensing Requirements for Veterinary Biologics in the United
States
|
|
3:30 4:00
|
Trujillo, Jessie
Dr. Jessie Trujillo, Utah Veterinary Diagnostic Laboratory, Animal, Dairy and
Veterinary Services, Utah State University, Logan UT
Overcoming Deceptive Imprinting: Immune Refocusing Technology as a
Proof-of-Concept using the Caprine Arthritis Encephalitis Virus (CAEV)
Vaccine
Model
|
|
4:00 4:30
|
Concluding Remarks Dr. Ronald D. Schultz
|
